Syndax Pharmaceuticals Inc short interest in 2020
In 2020, Syndax Pharmaceuticals Inc's disclosed short interest ran from 2.25% of shares outstanding on 15 Jan 2020 to 13.50% on 31 Dec 2020, a change of +11.25 percentage points. The year's high was 13.50% on 31 Dec 2020 and its low 2.25% on 15 Jan 2020, averaging 8.61% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.12 days on 31 Aug 2020. Full history: Syndax Pharmaceuticals Inc.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 2.25% (15 Jan 2020)
- End of year
- 13.50% (31 Dec 2020)
- Change
- +11.25 pp
- High
- 13.50% (31 Dec 2020)
- Low
- 2.25% (15 Jan 2020)
- Average
- 8.61%
- Highest days to cover
- 18.12 (31 Aug 2020)
- SEC filings marked
- 9
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 2.25% | 6.72 | |
| 31 Jan 2020 | 2.55% | 6.17 | |
| 14 Feb 2020 | 3.10% | 4.89 | |
| 28 Feb 2020 | 3.30% | 3.42 | |
| 13 Mar 2020 | 3.99% | 4.43 | results (8-K), 10-K filed |
| 31 Mar 2020 | 5.94% | 7.72 | |
| 15 Apr 2020 | 5.86% | 10.30 | |
| 30 Apr 2020 | 5.83% | 1.06 | results (8-K) |
| 15 May 2020 | 7.43% | 3.15 | 10-Q filed, results (8-K) |
| 29 May 2020 | 9.56% | 1.87 | |
| 15 Jun 2020 | 10.64% | 7.86 | |
| 30 Jun 2020 | 12.63% | 7.22 | |
| 15 Jul 2020 | 11.86% | 13.41 | |
| 31 Jul 2020 | 11.30% | 17.43 | |
| 14 Aug 2020 | 9.20% | 11.47 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 9.31% | 18.12 | |
| 15 Sep 2020 | 9.48% | 14.86 | |
| 30 Sep 2020 | 11.66% | 11.99 | |
| 15 Oct 2020 | 11.93% | 10.49 | |
| 30 Oct 2020 | 11.36% | 7.09 | |
| 13 Nov 2020 | 11.26% | 5.35 | results (8-K), 10-Q filed |
| 30 Nov 2020 | 11.08% | 9.40 | |
| 15 Dec 2020 | 11.68% | 6.29 | |
| 31 Dec 2020 | 13.50% | 6.81 |
See also: Syndax Pharmaceuticals Inc's full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.